Goldman Sachs rates Vaxcyte a buy with $135 price target, highlighting vaccine platform and pneumonia candidate. Read more ...

As we are approaching winter and there is an increase in respiratory diseases, it’s also important to know about pneumococcal ...

Pneumonia is a lung infection that annually impacts millions of people around the globe, according to the Centers for Disease ...

I just turned 57, and my doctor is now saying that I should get vaccinated for pneumonia. The only time I ever had pneumonia was one time when I had a bad case of the flu. Why isn’ t he talking about ...